Life Sciences Ontario commissioned Research Etc., an established Toronto research firm, to conduct a survey of pharmaceutical and other life sciences leaders on the Canadian price regulations policy environment. Preliminary results of the survey are now available, drawing on 23 responses from unique organizations representing Canadian and global pharma leaders….
News
Writer: GLENN LOWSON/THE GLOBE AND MAIL Close to 300 people gathered at The Globe and Mail Centre on November 14 to join a conversation on growth strategies for the Canadian biomedical sector. Speakers agreed Canada punches above its weight in early-stage research and clinical trials but has yet to produce…
Canadian researchers have given the world insulin, pacemakers and the discovery of stem cells, and are making headway in a number of biomedical fields, including artificial intelligence, medical imaging, quantum computing and cannabis-based treatments. Aside from research and innovation, the potential for economic success in the biomedical field is massive,…
MISSISSAUGA, Ontario — Today, BioTalent Canada and Life Sciences Ontario (LSO) announced the launch of The PetriDish™ Life Sciences Ontario job board, providing companies in one of Canada’s largest biotech hubs with a platform to attract talent. The launch of an Ontario bio-economy job board comes at a time when…
Re A Cure For Canada’s High Drug Prices (Aug. 13): The Globe and Mail compares the Liberals’ redesign of the Patented Medicine Prices Review Board to renovations on a house, with the PMPRB being the health-care system’s “plumbing.” The analogy is apt, but the conclusion that the changes are reasonable is wrong….
Complicated new regulations will set maximum allowable prices for new medicines too low to justify research and launch of medicines in Canada Changes will also exacerbate potential for mass diversion of lower-priced Canadian medicines to the United States EDMONTON, TORONTO and MONTREAL, Aug. 9, 2019 /CNW/ – The federal government’s new regulations for setting the maximum allowable…
A Response to the Advisory Council’s report on the Implementation of National Pharmacare and PMPRB Last September, Life Sciences Ontario (LSO) made a submission to the Advisory Council on the Implementation of National Pharmacare, led by Eric Hoskins. Our quick review of the Hoskins Council report that was tabled yesterday…
BioTalent Canada and Life Sciences Ontario expand partnership with the release of The PetriDish™ Life Sciences Ontario job board Mississauga, ON – May 31, 2019 – Today, BioTalent Canada and Life Sciences Ontario (LSO) announced the launch of The PetriDish™ Life Sciences Ontario job board, providing companies in one of…
VIA EMAIL AND POSTED PUBLICLY April 17, 2019 The Rt. Hon. Justin Trudeau, PC, MPOffice of the Prime Minister80 Wellington StreetOttawa ON K1A 0A2 Subject: On PMPRB reform, political leadership and evidence-based approach needed Dear Prime Minister Trudeau, On March 7, 2019, we wrote a letter (attached as Appendix B)…
Accelerating Prosperity: The Life Sciences Sector in Ontario Deloitte estimates that the Ontario life sciences sector produces $27 billion of economic output, making it one of the largest sectors in the provincial economy. March 1st, 2019 – Toronto, ON – It’s safe to say, Ontario’s life sciences sector is a…